Loading organizations...
§ Venture Capital · 676 North Michigan Avenue Suite 4000, Chicago, IL 60611, United States
Satter Medical Technology Partners is an investment firm specializing in the medical technology sector. It provides strategic capital to companies developing innovative solutions across medical devices, diagnostics, and therapeutic technologies. The firm aims to accelerate commercialization and adoption of advancements that significantly impact patient care and enhance healthcare delivery.
Muneer A. Satter established the firm in 2016, serving as Managing Partner. Satter drew upon extensive financial expertise, including senior roles at Goldman Sachs, to create this focused investment platform. His foundational insight recognized the pressing need for dedicated capital and specialized guidance for medical technology companies navigating complex market pathways.
The firm partners with promising medical technology companies seeking investment and strategic support for growth and market expansion. Satter Medical Technology Partners endeavors to catalyze innovation, facilitating development and widespread deployment of technologies that improve clinical outcomes and operational efficiencies. Its vision is to contribute to a more advanced and accessible global healthcare system.
Satter Medical Technology Partners has 1 tracked investment across 1 company. The latest tracked deal is $100.0M Other Equity in Annexon Biosciences in July 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 2, 2020 | Annexon Biosciences | $100.0M Other Equity | Redmile Group | Adage Capital Management, Bain Capital Life Sciences, BlackRock, Blackstone, Deerfield Management, Eventide Asset Management, Farallon Capital Management, Janus Henderson Investors, Logos Capital, NEW Enterprise Associates, Surveyor Capital |